Ch. 7— The Use of Animals in Testing • 171 
46. Schaumburg; H.H., and Spencer, P., "Central and 
Peripheral Nervous System Degeneration Produced 
by Pure n-Hexane: An Experimental Study,” Brain 
99:183-192, 1976. 
47. Schenebeck v. Sterling Drug, Inc., 423 F.2d 919 (8th 
Cir. 1970). 
48. Sieracki v.Seas Shipping Company , 57 F.Supp. 724 
(E.D.Pa. 1944). 
49. Stromsodtv. Parke -Davis and Company, 257F.Supp. 
991 (D.N.D. 1966), affirmed, 411 F.2d 1390 (8th Cir. 
1969). 
50. Swanston, D.W., “Eye Irritancy Testing,” Animals 
and Alternatives in Toxicity Testing, M. Balls, R.J. 
Riddell, and A.N. Worden (eds.) (New York: Aca- 
demic Press, 1983). 
51. Tinnerholm v. Parke-Davis and Company, 411 F.2d 
48 (2nd Cir. 1969). 
52. Trevan, J.W., "The Error of Determination of Tox- 
icity,” Proc. R. Soc. Lond. (Biol.) 101:483 (1927). 
53. U.S. Congress, Office of Technology Assessment, 
Assessment of Technologies for Determining Can- 
cer Risks From the Environment, OTA-H-138 (Wash- 
ington, DC: U.S. Government Printing Office, June 
1981). 
54. U.S. Environmental Protection Agency, "Acute Ex- 
posure: Oral Toxicity,” Office of Toxic Substances 
Health and Environmental Effects Test Guidelines 
(Washington, DC: updated October 1984). 
55. U.S. Executive Office of the President, Office of 
Science and Technology Policy, “Chemical Carcino- 
gens: A Review of the Science and Its Associated 
Principles,” Mar. 14, 1985. 
56. U.S. Food and Drug Administration, Toxicological 
Principles for the Safety Assessment of Direct Food 
Additives and Color Additives Used in Food (Wash- 
ington, DC: Bureau of Foods, 1982.) 
57. U.S. v . An Article of Drug— Bacto Unidisk, 394 U.S. 
784, 792 (1968). 
58. Weigland, D.A., Haygood, C., and Gaylor, J.R., "Cell 
Layer and Density of Negro and Caucasian Stratum 
Corneum,” J. Invest. Dermatol. 62:563-568, 1974. 
